What Next? New Drugs, Old Drugs, and New Challenges in Choosing Treatments for Covid-19.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38319796.
- Also identified by DOI 10.1056/EVIDe2200189.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Much has changed since March 2020, when the World Health Organization declared Covid-19 a pandemic and clinicians around the world began desperately searching for therapies that could help afflicted patients. Barely 2.5 years after SARS-CoV-2 was discovered, we have solid evidence for the efficacy and safety of repurposed and novel agents for pre- and postexposure prophylaxis and for mild and severe disease, not to mention highly effective vaccines.
Medical subject headings
- COVID-19